Pfizer Inc. (PFE) saw a 6.83% jump on Tuesday, closing at $25.48, as it was exempted from the US government’s 100% tariff on pharmaceutical imports. The company agreed to lower prescription drug costs for American patients and ensure comparable pricing to other developed countries for new medicines. Pfizer will also offer discounts through TrumpRx.gov.

The agreement with the US government shields Pfizer Inc. (PFE) from the impending 100% tariff on pharmaceutical imports starting October 1. While Pfizer shows promise as an investment, some AI stocks may offer higher returns with limited downside risk. For details on a cheap AI stock benefiting from Trump tariffs, check out the free report on the best short-term AI stock.

Read more at Yahoo Finance: Pfizer (PFE) Soars on Tariff Exemption, Landmark US Govt Deal